European Lithium (Australia: EUR.AX) – last price 26.5c – ~A$450mm market cap

Thesis summary: European Lithium is a near-busted merger trading not far from cash backing, where I believe you get paid in most all states of the world. The announced all-scrip acquisition of EUR by Critical Metals Corp (Nasdaq: CRML) – a deal struck at an implied ~58c per EUR share back in April – is, at current CRML prices, worth only ~32c per share, versus a standalone sum-of-the-parts in the mid/high 40c per share, of which a good chunk (~18c per share) is hard net cash. No independent expert can bless the deal as it stands; no rational shareholder base would vote it through; and thus the current terms are, quite simply, dead on arrival.

Crucially, however, CRML needs this deal far, far more than EUR does, because this is essentially a cash-for-shares transaction: CRML is buying EUR’s ~A$306mm cash pile (and cancelling the 45.5mm CRML shares EUR owns) to fund the development of its Tanbreez rare earths project in Greenland, for which only a fraction of the required capital is currently lined up. That means the overwhelmingly likely outcome is a recut deal at materially better terms – I think somewhere in the mid-40s, more or less replicating standalone value – or, failing that, a total deal break followed by some other value-extraction exercise (a restarted buyback being the obvious candidate) under pressure from an already-disgruntled register.

Either way, with the stock at 26.5c against 18c of net cash backing, I struggle to see how you lose much from here, whilst the path to 40c+ – call it 50-70% upside – looks reasonably short-dated. This is right in my wheelhouse (small-cap Australian event-driven, with an activist kicker), and I have taken a position – though given the residual hair here (to be discussed), I would only be loading the boat down 10% or so from current; for now it is still cheap enough for a smallish swing.

Background: how we got here

A quick potted history is necessary, because the corporate structure here is – shall we say – idiosyncratic. EUR began life as the owner of the Wolfsberg lithium project in Austria, which it vended into a SPAC (see here) to create Critical Metals Corp, a Nasdaq-listed ‘critical minerals’ vehicle chaired (and now also run) by EUR’s own Executive Chairman, Tony Sage. CRML subsequently acquired the Tanbreez rare earths project in Greenland – now 92.5% owned after the Greenland government approved the final tranche transfer, with the residual 7.5% sitting, conveniently enough, at EUR. Along the way, EUR has been steadily monetizing its CRML shareholding into strength – three block sales raising ~US$121mm, including one US$50mm clip to a US institution (see also here) – such that by March 31 this year the company was sitting on ~A$306mm of cash and ~US$18mm of other marketable securities, against a residual holding of 45.5mm CRML shares (roughly 31% of CRML’s outstanding) – all per the deal announcement itself.

In other words, EUR today is a cash box with the large CRML stake and a few other residual equity stakes: no operating business, no capex commitments of its own, and a management team with an, ahem, ‘colourful’ history of related-party dealings between the various entities in the stable. The stock, perhaps unsurprisingly, has traded at a yuuuge discount to asset value for most of its recent existence – indeed the company announced an on-market buyback (~A$15mm) when the stock languished around 11-13c, before the deal machinations emerged.

Then, in late April, came the ‘solution’: CRML announced it would acquire EUR outright, via two interdependent Australian schemes of arrangement (one for the shares, one for the listed options), at a fixed exchange ratio of 0.035 CRML shares per EUR share – a headline ~US$835mm transaction, pitched at an implied ~58c per EUR share against the then-prevailing CRML price north of US$11, and trumpeted as a 137% premium. The cross-holding – EUR’s 45.5mm CRML shares – would simply be cancelled on completion. Binding scheme implementation documents were signed in mid-May (the full ASX announcement is here, and CRML’s corresponding SEC filing here). The scheme meeting has been guided to occur in 3Q, with deal completion 2H 2026.

The problem, of course, is what has happened since: CRML stock has roughly halved, to ~US$6.4. And because the exchange ratio is fixed, the ‘premium’ has evaporated along with it. Therein lies our opportunity today.

What is EUR actually worth standalone?

The beauty of this situation is that the sum-of-the-parts requires no heroics and is pretty self-explanatory with entirely listed assets (both liquid, too). On ~1.7bn shares outstanding, here is how it breaks down:

Most of this should be pretty straightforward. The cash is simply the residue of the prior CRML block sell-downs). The CRML stake is marked to a liquid Nasdaq quote, with no control premium assumed (despite it being a 31% blocking stake in practice). The direct Tanbreez interest I am carrying at half its look-through value – CRML’s ~US$900mm market cap for 92.5% of the project implies ~US$73mm for EUR’s 7.5%, and I am taking ~US$35mm, i.e. treating most all of it as semi-gravy – whilst the corporate cost line is my own (deliberately punitive) estimate. Note what is NOT in there: nothing for the US$3bn PEA valuation CRML itself touts for Tanbreez, and nothing for any deal premium. This is simply a mark-to-market ‘liquidation-style’ SoTP, nothing more.

Adding it all up: 18c of cash, plus 24c of look-through CRML, plus change, gets you to ~46c per share, against a 26.5c quote. That is to say, the market is currently valuing EUR at under 60c on the dollar of a SoTP where nearly half the value is cash.

Thesis point #1: the current merger is dead

Comparing standalone SOTP to the current implied deal value is where the math becomes almost comically untenable. At the April measurement date, 0.035 CRML shares were worth ~58c AUD per EUR share – a fat premium to standalone SoTP at the time, and you can see why the EUR board waved it through (even though that price was also, at the time, a chunky discount to then-SOTP). Today, at US$6.4, that same 0.035 shares is worth ~US22.4c, or ~32c AUD.

So the choice facing an EUR shareholder at current terms is:

• Take the deal: receive ~32c per share, entirely in CRML paper, with your 18c of cash handed over to CRML in the process; or
• Vote it down: keep a company worth ~46c per share mark-to-market, of which 18c is hard cash backing.

Putting it another way, an EUR holder already owns ~25-26c per share of CRML on a look-through basis. Accepting the scheme therefore means handing over 18c per share of hard cash in exchange for roughly 7c per share of incremental CRML exposure. You would be paying nearly three dollars for every incremental dollar of CRML stock – stock you could simply buy on the market, today, with no scheme risk attached. I am hard pressed to recall a scrip deal that has decayed quite this egregiously against the target while the parties continue, publicly at least, to proceed as if nothing has happened.

And this is before we get to the procedural reality. This is an Australian scheme of arrangement between two entities that share an Executive Chairman – about as conflicted a transaction as you will see – meaning an Independent Expert must opine that the scheme is fair and reasonable and/or in the best interests of EUR shareholders before it can even be put to the vote. I would love to sit in on the meeting where an IER concludes that 33c of volatile scrip is ‘fair’ consideration for 45c of assets, 18c of which is cash; it simply cannot be written at current prices, and every day CRML languishes down here makes the expert’s task more impossible.

The interesting thing here however is that the market – at 26.5c – is still pricing this on some kind of arbitrage spread to the 32c (admittedly a wide spread but it has been wide ever since the deal was papered) – rather than with reference to the underlying cash floor, or with regard to what likely happens next. This (in my view) is our opportunity.

Thesis point 2: CRML needs this deal far more than EUR does

A further oddity about this deal is the extent to which it is being structured purely for the benefit, and in the interests of, one of the parties. I suppose it is not entirely surprising (because Tony Sage sits on both sides of the fence) but at the same time, even a cursory look at the situation demonstrates CRML needs this deal to happen and really to happen pretty fast (in the next six months). For EUR, the scheme is optional: fail to complete, and shareholders are left holding a cash box at a discount – annoying, but hardly fatal. Not so for CRML. Consider what they would get: ~A$306mm (~US$220mm) of cash; the cancellation of a 31% cross-holding (cleaning up a big overhang and legacy crossholding structure); and the residual 7.5% of Tanbreez, taking the project to 100%. Against that, CRML issues perhaps 65-70mm new shares gross across the schemes – but cancels the 45.5mm cross-holding shares, for net issuance of only ~20-25mm shares, worth ~US$140-160mm at the current quote. That is to say, CRML is printing ~US$150mm of paper to acquire ~US$235mm of cash and liquid assets, plus the Tanbreez minority (worth $70mm again referencing current CRML spot), or around $300mm in total value. Not a bad day at the office if CRML can get it!

But CRML is running up against funding needs at Tanbreez. Management’s own feasibility-level guidance puts all-in Tanbreez capex at US$800mm-1bn, of which US$400-600mm is the Greenland mine and concentrator (and given cost inflation, is likely going to rise further). Near-term, they have guided to US$40-50mm of spend over the next 12-18 months just to keep the development timeline alive. Against this, so far they have really only announced a US$120mm Letter of Interest from the US EXIM Bank for a 15-year term loan; a grab-bag of offtake arrangements (a Saudi JV taking 25% of concentrate, Romanian and US partners covering the rest). The reality is the CRML balance sheet is, absent the EUR transaction, significantly undercapitalized for a project of this scale.

This means the EUR cash pile essentially solves the equity component of the mine/concentrator build in one stroke – and, crucially, government lenders like EXIM do not convert LOIs into committed facilities for borrowers without a demonstrated equity cushion. Solving the EUR merger, therefore, IS the financing strategy. Walking away from ~US$220mm of friendly, captive cash – to go raise the same money from arm’s-length markets, with the stock halved – would be nigh on self-immolation. Sage sits on both sides of the table, and both of his hats point in the same direction: get this deal done, at whatever ratio it takes.

Scenario analysis: what are the options from here?

Scenario 1: the merger is recut (my base case). The cleanest fix is simply a revised exchange ratio. The original deal handed EUR holders ~58c of value; the current one hands them ~32c; the gap is ~25c per share. For an Independent Expert to get to ‘fair and reasonable’ – and for the register to vote yes – I believe total consideration needs to travel at least half the distance back, i.e. north of 45c per EUR share, which (not coincidentally) is more or less where standalone SoTP sits. Mechanically that implies a ratio of ~0.047-0.048 CRML shares per EUR share, versus 0.035 today – a bump CRML can readily afford given the deal remains wildly accretive to them even at the higher ratio (they would still be issuing net paper worth less than the cash acquired). ~45c of consideration against a 26.5c stock is ~70% upside, on what should be a 2H 2026 timeline.

Scenario 2: the deal breaks entirely (unlikely, but possible). Say CRML craters further, or the parties simply cannot agree on a recut, and the schemes lapse. What then? EUR reverts to being a cash box at ~60% of SoTP, with a shareholder base that has now been shown 58c, then 32c, and will be in no mood for excuses. The pressure to return capital would be immediate and, I suspect, irresistible – recall this company was already running an on-market buyback before the deal put it on ice. With A$306mm of cash against a ~A$450mm market cap, EUR could tender for a very substantial slice of its own register at a healthy premium to the current price and still remain comfortably cash-backed; every share retired below cash-plus-stake value is mechanically accretive to those who remain. Would management prefer to hoard the cash for the next adventure or another CRML merger attempt? Of course they would – but the register knows exactly what is in the tin now, and this is precisely the sort of situation where a little organized shareholder agitation (ahem) goes a long way. More pertinently, they cannot advance Tanbreez – the actual potential home-run that Sage et al are ostensibly in this for – without coming back to the table, and given we are unlikely to ever see such a pro-Greenland, pro-rare earth development administration like this in our lifetimes, I would be shocked if a recut deal wasn’t tabled in some form sooner than later.

Risks

CRML price risk. I need to be quite upfront about what CRML is currently: a pre-revenue, PEA-stage rare earths developer in Greenland, with no underlying cash flow, whose equity value rests entirely on your view of Tanbreez, its development timeline, and the durability of the critical-minerals geopolitical bid. I hold no strong view on any of these and if CRML craps out completely the SoTP travels south with it. My rejoinder is simply the cash: at a 26.5c entry you are underwritten by 18c per share of net cash – roughly two-thirds of the price – such that even a further halving of CRML from here leaves SoTP around 31-33c, still above the current quote. That is enough margin of safety for me, but size accordingly: this is not a riskless cash-backed arb, it is a discounted cash box stapled to a volatile story stock.

Sage/related party risk. Tony Sage’s reputation for running listed vehicles with, let us say, an elastic approach to related-party arrangements precedes him, and I will not insult readers by pretending otherwise. However I would make two observations. First, this risk is precisely why the stock trades at 60c on the dollar – that is this exact risk is significantly in the price already. Second, the current setup is unusually constraining for a promoter: the scheme process shines a very public light on value (courtesy of the forthcoming IER); the cross-holding means value destruction at EUR now directly impairs CRML’s own funding path; and the register has a hard, recent reference point (58c) to anchor its indignation to. So while there is certainly a decent amount of hair here, it is at least hair you are being paid handsomely to hold.

Putting it all together

At 26.5c you are creating EUR at under 60% of a mark-to-market SoTP, with 18c of net cash underneath you, a dead deal that almost has to be recut higher (because the acquirer cannot afford to walk), and a fallback path – buyback/capital return under shareholder pressure – that gets you paid in the break scenario too. The catalysts are near-term and legible: the Independent Expert’s report and (more likely) revised terms ahead of a 3Q scheme meeting, with completion (or a very loud break) guided for 2H this year. Base case, a recut in the mid-40s is worth ~70% from here; bear case, the cash floor limits the damage. Multiple ways to win, a hard floor, and a short clock – that’s the kind of setup I came back to write about.

Disclosure: long EUR.AX. Do your own due diligence. This is not investment advice and constitutes solely my own opinion, and should be read for entertainment purposes only.